论文信息 - Metastatic Cutaneous Apocrine Adenocarcinoma Treated With a Combination of Pertuzumab-Based Targeted Therapy and Taxane Chemotherapy: A Case Report. - 字舞流文

Metastatic Cutaneous Apocrine Adenocarcinoma Treated With a Combination of Pertuzumab-Based Targeted Therapy and Taxane Chemotherapy: A Case Report.

T. Shien | O. Yamasaki | K. Iwatsuki | Masaki Otsuka | Tatsuya Kaji

[1] Sung-Bae Kim,et al. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. , 2015, The New England journal of medicine.

[2] B. Ljung,et al. Breast Cancer, Version 3.2013 , 2013 .

[3] M. Mizuashi,et al. Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine. , 2012, Acta dermato-venereologica.

[4] Sung-Bae Kim,et al. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. , 2012, The New England journal of medicine.

[5] Werner Scheuer,et al. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. , 2009, Cancer research.

[6] N. Foman,et al. Primary cutaneous apocrine carcinoma presenting as carcinoma erysipeloides , 2007, The British journal of dermatology.